Technical efficiency of Ukrainian pharmaceutical firms: Evidence from the COVID-19 pandemic and Russia-Ukraine war
-
DOIhttp://dx.doi.org/10.21511/ppm.23(1).2025.52
-
Article InfoVolume 23 2025, Issue #1, pp. 703-716
- 51 Views
-
5 Downloads
This work is licensed under a
Creative Commons Attribution 4.0 International License
This paper examines the influence of marketing expenses and total assets on the technical efficiency of big Ukrainian pharmaceutical producers during the COVID-19 pandemic and the war in Ukraine. The data were collected from the nine leading pharmaceutical firms for six years, covering 2018–2023. Input-oriented data envelopment analysis was used, with revenue serving as the output and raw materials, sales, and general and administrative expenses as the inputs. The study found that the COVID-19 pandemic and the onset of the full-scale invasion of Russia in Ukraine caused a decline in efficiency, although not statistically significant. The analysis showed that around 70% of pharmaceutical firms need to increase the scale of operations to achieve efficiency. Additionally, smaller and older firms were found to have better efficiency. The research findings show that marketing productivity is positively associated with pure efficiency, while marketing expenses have the opposite impact with coefficients 0.064 and –0.05, respectively. Finally, a substantial increase in slacks during the COVID-19 pandemic propelled managers to find ways to cut sales and general and administrative costs. The results underscore the importance of cost optimization policies, along with asset and business-scale management in maintaining the efficiency of Ukrainian pharmaceutical firms.
- Keywords
-
JEL Classification (Paper profile tab)L11, L25, M21
-
References44
-
Tables9
-
Figures1
-
- Figure 1. Impact of omitted variables on the OTE
-
- Table 1. List of variables used in the study
- Table 2. Descriptive statistics of Ukrainian pharmaceutical firms during 2018–2023
- Table 3. Correlations between inputs and output
- Table 4. Regression output
- Table 5. Firm trends in efficiency and returns to scale
- Table 6. Efficiency trends in Ukraine’s pharmaceutical industry
- Table 7. Spearman’s rank correlation coefficients
- Table 8. Tobit regression
- Table 9. The trends in returns to scale of Ukrainian pharmaceutical firms
-
- Aggrey, N., Eliab, L., & Joseph, S. (2010). Firm size and technical efficiency in East African manufacturing firms. Current Research Journal of Economic Theory, 2(2), 69-75.
- Ambler, T. (2003). Marketing and the bottom line: Creating the measures of success. London: Financial Times/Prentice Hall.
- Azad, Md. A. K., Munisamy, S., Teng, K. K., Talib, M. B. A., & Saona, P. (2018). Productivity changes of pharmaceutical industry in Bangladesh: Does process patent matter? Global Business Review, 19(4), 1013-1025.
- Badunenko, O., & Tauchmann, H. (2019). Simar and Wilson two-stage efficiency analysis for Stata. The Stata Journal, 19(4), 950-988.
- Banker, R. D., Charnes, A., & Cooper, W. W. (1984). Some models for estimating technical and scale inefficiencies in data envelopment analysis. Management Science, 30(9), 1078-1092.
- Bhattacharyya, S., & Chatterjee, S. (2020). Efficiency evaluation of selected Indian pharmaceutical firms since inception of product patent. International Journal of Management Concepts and Philosophy, 13(4), 292-318.
- Bonoma, T. V., & Clark, B. H. (1988). Marketing performance assessment. Boston: Harvard Business Review Press.
- Bontis, N. (1998). Intellectual capital: An exploratory study that develops measures and models. Management Decision, 36(2), 63-76.
- Caglar, M., & Nisel, R.N. (2017). Impact of marketing and R&D expenditures on financial performance: A research in manufacturing industry. Research Journal of Business and Management, 4(3), 359-371.
- Charnes, A., Cooper, W. W., & Rhodes, E. (1978). Measuring the efficiency of decision making units. European Journal of Operational Research, 2(6), 429-444.
- Cooper, W. W., Seiford, L. M., & Tone, K. (2007). Data envelopment analysis: A comprehensive text with models, applications, references and DEA-solver software. New York: Springer.
- Díaz, R. F., & Sanchez-Robles, B. (2020). Non-parametric analysis of efficiency: An application to the pharmaceutical industry. Mathematics, 8(9), 1522-1548.
- Donthu, N., Hershberger, E. K., & Osmonbekov, T. (2005). Benchmarking marketing productivity using data envelopment analysis. Journal of Business Research, 58(11), 1474-1482.
- Duffy, M. (2002). Measuring marketing ROI… Great, but usually late. In S.C. Bahadir & K.R. Tuli (Eds.), Measuring marketing productivity: Linking marketing to financial returns. Cambridge: Marketing Science Institute.
- Foster, G., & Gupta, M. (1994). Marketing, cost management, and management accounting (Working Paper No. 1309). Stanford Graduate School of Business.
- Gagnon, M.-A., & Lexchin, J. (2008). The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Medicine, 5(1).
- Goncharuk, A. G., & Getman, M. (2014). Benchmarking to improve a strategy and marketing in pharmaceuticals. Benchmarking: An International Journal, 21(3), 364-385.
- Jaisinghani, D., & Kanjilal, K. (2019). Marketing investments and firm performance in manufacturing sector: A panel threshold model for China. Journal of the Asia Pacific Economy, 24(1), 117-126.
- Krasnikov, A., & Jayachandran, S. (2008). The relative impact of marketing, research-and-development, and operations capabilities on firm performance. Journal of Marketing, 72(4), 1-11.
- Kumar, V., & Petersen, J.A. (2004). Maximizing ROI or profitability. Marketing Research: A Magazine of Management and Applications, 16(3), 28-34.
- Mahajan, V., Nauriyal, D. K., & Singh, S. P. (2014). Technical efficiency analysis of the Indian drug and pharmaceutical industry: A non-parametric approach. Benchmarking: An International Journal, 21(5), 734-755.
- Mahajan, V., Nauriyal, D. K., & Singh, S. P. (2018). Efficiency and its determinants: Panel data evidence from the Indian pharmaceutical industry. Margin – The Journal of Applied Economic Research, 12(1), 19-40.
- Makadok, R. (2001). Toward a synthesis of the resource-based and dynamic-capability views of rent creation. Strategic Management Journal, 22(5), 387-401.
- Mazumdar, M. (Ed.). (2013). The sources of heterogeneity in the efficiency of Indian pharmaceutical firms. In Performance of Pharmaceutical Companies in India (pp. 45-71). Heidelberg: Physica.
- Mazumdar, M., & Rajeev, M. (2009). A comparative analysis of efficiency and productivity of the Indian pharmaceutical firms: A Malmquist-meta-frontier approach (Working Paper No. 223). Bangalore, India: Institute for Social and Economic Change.
- Moorman, C. (2016). The CMO Survey: Firm and Industry Breakout Report.
- Mostafa, M. (2007). Benchmarking top Arab banks’ efficiency through efficient frontier analysis. Industrial Management & Data Systems, 107(6), 802-823.
- Nath, P., Nachiappan, S., & Ramanathan, R. (2010). The impact of marketing capability, operations capability and diversification strategy on performance: A resource-based view. Industrial Marketing Management, 39(2), 317-329.
- Obukohwo, E. O., Olele, E. H., & Buzugbe, P. N. (2018). Assessing efficiency in the pharmaceutical sector of Nigeria. CBN Journal of Applied Statistics, 9(2), 131-148.
- Olasiuk, H. P., Bhasker, S., & Patra, S. (2020). Cash dividends and share repurchases in Ukrainian pharmaceutical companies. Global Business Review, 25(2_suppl), S7-S22.
- Pannu, H. S., Kumar, D. U., & Farooquie, J. A. (2011). Efficiency and productivity analysis of Indian pharmaceutical industry using data envelopment analysis. International Journal of Operational Research, 10(1), 121-136.
- Park, H. Y., Shin, G. C., & Jurn, I. (2009). Corporate strategies and performances of Korean firms: The unified theory of the firm perspective. Global Economic Review, 38(2), 185-203.
- Powell, G. R. (2002). Return on marketing investment: Demand more from your marketing and sales investments. United States: RPI Press.
- Ryoo, J., Jeon, J.Q., & Lee, C. (2016). Do marketing activities enhance firm value? Evidence from M&A transactions. European Management Journal, 34(3), 243-257.
- Saranga, H., & Phani, B.V. (2009). Determinants of operational efficiencies in the Indian pharmaceutical industry. International Transactions in Operational Research, 16(1), 109-130.
- Scafarto, V., Ricci, F., & Scafarto, F. (2016). Intellectual capital and firm performance in the global agribusiness industry: The moderating role of human capital. Journal of Intellectual Capital, 17(3), 530-552.
- Schiersch, A. (2013). Firm size and efficiency in the German mechanical engineering industry. Small Business Economics, 40, 335-350.
- Simanjuntak, D. G., & Tjandrawinata, R. R. (2011). Factors influencing sales revenue in the multinational pharmaceutical companies. SSRN Electronic Journal.
- Simar, L., & Wilson, P.W. (2007). Estimation and inference in two-stage, semi-parametric models of production processes. Journal of Econometrics, 136(1), 31-64.
- SMIDA. (2022). Ahentstvo z rozvytku infrastruktury fondovoho rynku Ukrainy [Stock Market Infrastructure Development Agency of Ukraine]. (In Ukrainian).
- Suh, T., Yi, H. C., & Houston, M. B. (2011). Reassessing firm size in international marketing research. Journal of Global Marketing, 24(1), 85-99.
- Veltri, S. (2008). Empirical evidence of relationships between intellectual capital performance and firm value. Economia Aziendale Online, 1(2-3), 101-118.
- Vorhies, D.W., & Morgan, N.A. (2003). A configuration theory assessment of marketing organization fit with business strategy and its relationship with marketing performance. Journal of Marketing, 67(1), 100-115.
- Wang, C. Y., & Wu, L. W. (2012). Customer loyalty and the role of relationship length. Managing Service Quality: An International Journal, 22(1), 58-74.